CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Daily low-dose Tacrolimus (TAC) is a save and efficient immunosuppressive regimen during triple drug therapy post liver transplant
DOI 10.1055/s-0033-1352742
Bibliografische Angaben
Nachweis in CareLit
Autor:innenA Papadopoulos-Köhn, J Timm, C Jochum, A Paul, A Canbay, G Gerken, K Herzer
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2013
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Graft loss from hepatitis C virus (HCV) recurrence remains a major problem after liver transplantation (LT), and the response to standard therapy is poor. Triple therapy opens a new perspective for better graft and patient survival but severe drug interactions are a potential limitation in LT patients. We report our experience using low-dose tacrolimus (TAC) on a daily base in patients who undergo HCV triple t…
Zitieren
Zitierempfehlung
A Papadopoulos-Köhn, J Timm, C Jochum, A Paul, A Canbay, G Gerken, K Herzer (2013) Daily low-dose Tacrolimus (TAC) is a save and efficient immunosuppressive regimen during triple drug therapy post liver transplant. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0033-1352742
Mit CareLit weiterarbeiten